| Literature DB >> 7930408 |
Y Takeuchi1, Y Miyanomae, H Komatsu, Y Oomizono, A Nishimura, S Okano, T Nishiki, T Sawada.
Abstract
Children with spinal muscular atrophy were treated by the administration of thyrotropin-releasing hormone. In three infants with spinal muscular atrophy type I, thyrotropin-releasing hormone showed little efficacy, but in children with types II and III, there was improvement in motor function and electromyographic findings after the thyrotropin-releasing hormone therapy. Thyrotropin-releasing hormone has a neurotrophic effect on the spinal anterior motor neurons of spinal muscular atrophy patients and thus may be warranted for the management of spinal muscular atrophy.Entities:
Mesh:
Substances:
Year: 1994 PMID: 7930408 DOI: 10.1177/088307389400900313
Source DB: PubMed Journal: J Child Neurol ISSN: 0883-0738 Impact factor: 1.987